Alectinib is a targeted therapy used for the treatment of non-small cell lung cancer. However, during the manufacturing process, impurities may be present in the final product. The presence of impurities can affect the safety and efficacy of the drug. Therefore, it is important to control and monitor the levels of impurities in Alectinib to ensure its quality and safety for human consumption.
![9-ethyl-6,6-dimethyl-10-(4-morpholinopiperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile](https://structures.clearsynth.com/9-ethyl-6-6-dimethyl-10--4-morpholinopiperidin-1-yl--11-oxo-6-11-dihydro-5H-benzo-b-carbazole-3-carbonitrile.png "Alectinib Impurities")
